Literature DB >> 16673117

Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case.

Junichi Shiraishi1, Hiroaki Nomori, Hideki Orikasa, Taisuke Mori, Kazuto Yamazaki.   

Abstract

We report a case of type-B3 thymoma manifesting neuroendocrine differentiation. The patient was a 42-year-old woman who complained of shoulder pain but had no symptoms of myasthenia gravis or anemia. The tumor was located in the anterior mediastinum and had directly invaded the pericardium and left lung. Histological examination revealed that the tumor was lobulated by bands of fibrous tissue, perivascular spaces were scattered throughout the tumor, and there were a few intraepithelial lymphocytes. The vast majority of lymphocytes in the perivascular spaces and in the lobulated tumor were immunohistochemically positive for TdT, MIC2, and CD1a. The majority of tumor cells were polygonal and medium or large in size. The tumor cells were weakly positive for synaptophysin, chromogranin A, CD56, and NSE. Small nests of small, relatively uniform polygonal cells were observed facing the fibrous bands. These cells resembled the cells of carcinoid tumors and were strongly positive for NSE, synaptophysin, chromogranin A, and CD56. Ultrastructurally, sparse dense-core granules were observed in the cytoplasm of a few tumor cells. This is a unique case of thymoma with neuroendocrine differentiation, and to the best of our knowledge this is the first such case ever reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673117     DOI: 10.1007/s00428-006-0218-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

1.  Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study.

Authors:  T T Kuo
Journal:  Histopathology       Date:  2000-07       Impact factor: 5.087

2.  Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases.

Authors:  C A Moran; S Suster
Journal:  Am J Clin Pathol       Date:  2000-03       Impact factor: 2.493

3.  Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.

Authors:  T Hishima; M Fukayama; Y Hayashi; T Fujii; K Arai; Y Shiozawa; N Funata; M Koike
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

4.  Immunohistochemical and in situ hybridization detection of growth-hormone-producing cells in human thymoma.

Authors:  L Lauriola; N Maggiano; F G Serra; S Nori; M L Tardio; A Capelli; M Piantelli; F O Ranelletti
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

5.  Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus.

Authors:  K Goto; T Kodama; Y Matsuno; T Yokose; H Asamura; N Kamiya; Y Shimosato
Journal:  Mod Pathol       Date:  2001-10       Impact factor: 7.842

6.  Neuroendocrine differentiation is a common feature of thymic carcinoma.

Authors:  L Lauriola; R A Erlandson; J Rosai
Journal:  Am J Surg Pathol       Date:  1998-09       Impact factor: 6.394

7.  Primary thymic carcinomas.

Authors:  M R Wick; B W Scheithauer; L H Weiland; P E Bernatz
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

8.  Human chorionic gonadotropin in the thymus. An immunocytochemical study on discordant expression of subunits.

Authors:  M Fukayama; Y Hayashi; Y Shiozawa; Y Maeda; M Koike
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

9.  Myoid cells and neuroendocrine markers in myasthenic thymuses.

Authors:  A Zółtowska; T Pawełczyk; M Stopa; J Skokowski; J Stepiński; A Roszkiewicz; W Nyka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1998       Impact factor: 4.291

10.  Thymic carcinoid tumor combined with thymoma--neuroendocrine differentiation in thymoma?

Authors:  K J Cho; C W Ha; J S Koh; J I Zo; J J Jang
Journal:  J Korean Med Sci       Date:  1993-12       Impact factor: 2.153

  10 in total
  4 in total

1.  Thymoma with ganglioneuroblastomatous component: case report.

Authors:  Kenji Kashiwabara; Hayato Ikota; Shigebumi Tanaka; Chie Ohta; Toshiki Yajima; Hideki Endoh; Ei Yamaki; Hiroyuki Kuwano; Takashi Nakajima
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

2.  Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1.

Authors:  Masaki Tomita; Nobuhiko Ichiki; Takanori Ayabe; Hiroyuki Tanaka; Hiroaki Kataoka; Kunihide Nakamura
Journal:  J Surg Case Rep       Date:  2017-04-04

3.  Single-cell transcriptional profiling of human thymic stroma uncovers novel cellular heterogeneity in the thymic medulla.

Authors:  Mark S Anderson; Audrey V Parent; Jhoanne L Bautista; Nathan T Cramer; Corey N Miller; Jessica Chavez; David I Berrios; Lauren E Byrnes; Joe Germino; Vasilis Ntranos; Julie B Sneddon; Trevor D Burt; James M Gardner; Chun J Ye
Journal:  Nat Commun       Date:  2021-02-17       Impact factor: 14.919

4.  Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers.

Authors:  Borislav A Alexiev; Cinthia B Drachenberg; Allen P Burke
Journal:  Diagn Pathol       Date:  2007-05-11       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.